Cargando…
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Depression is a common mental disorder and one of the leading causes of disability around the world. Monoaminergic antidepressants often take weeks to months to work and are not effective for all patients. This has led to a search for a better understanding of the pathogenesis of depression as well...
Autores principales: | Artin, Hewa, Zisook, Sidney, Ramanathan, Dhakshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209538/ https://www.ncbi.nlm.nih.gov/pubmed/34168967 http://dx.doi.org/10.5498/wjp.v11.i6.201 |
Ejemplares similares
-
Serotonergic Neuroplasticity in Alcohol Addiction
por: Belmer, Arnauld, et al.
Publicado: (2016) -
Towards an understanding of psychedelic-induced neuroplasticity
por: Calder, Abigail E., et al.
Publicado: (2022) -
Serotonergic Psychedelics in Neural Plasticity
por: Lukasiewicz, Kacper, et al.
Publicado: (2021) -
Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023) -
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
por: de Vos, Cato M. H., et al.
Publicado: (2021)